---
DrugClass: "[[Vaccines]]"
SubClass: "[[Vaccines and Toxoids]]"
DrugClassAdverse: "[[Vaccines and Toxoids#Adverse Reactions]]"
DrugClassContra: "[[Vaccines and Toxoids#Contraindications]]"
BrandName: Imovax, RabAvert
SecondaryDrugClass: 
SecondarySubClass: 
SecondaryAdverse: 
SecondaryContra: 
ThirdDrugClass: 
ThirdSubClass: 
ThirdAdverse: 
ThirdContra: 
FourthDrugClass: 
FourthSubClass: 
FourthAdverse: 
FourthContra: 
Chapter: "47"
KindleLinkChap: "[Chapter 47](kindle://book?action=open&asin=B09FRF11YJ&location=27339)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
aliases: 
SubCat: Vaccines, Viral (Special Populations)
---
```smiles

```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Prevention of rabies in people with greater risk (e.g., veterinarians, animal handlers, forest rangers); postexposure prophylaxis: bite by an animal suspected of carrying rabies 
Preexposure prophylaxis: 1Â mL IM, see package insert for dosing 
Postexposure: give vaccine IM after initial immune globulin injection 

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action


### Side/Adverse Effects
See `= this.DrugClassAdverse`
Transient pain, erythema, swelling or itching at the injection site, headache, nausea, abdominal pain, muscle aches, dizziness 

### Interactions

`= this.ChemLink+this.file.name`

